Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
Clinical trial NCT02076191 · COMPLETED
Trial details
- NCT number
- NCT02076191
- Sponsor
- John Mascarenhas
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2018-07-20
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.